Acute aortic dissection associated with wild-type transthyretin amyloid

被引：1
|
作者：
Mori, Shinichiro [1 ,2 ]
Hatae, Ryusuke [3 ]
Iwaki, Toru [1 ]
机构：
[1] Kyushu Univ, Grad Sch Med Sci, Dept Neuropathol, Fukuoka, Japan
[2] Saiseikai Futsukaichi Hosp, Dept Neurol, Fukuoka, Japan
[3] Kyushu Univ, Grad Sch Med Sci, Dept Neurosurg, Fukuoka, Japan
来源：
PATHOLOGY INTERNATIONAL | 2021年 / 71卷 / 08期
关键词：
SENILE SYSTEMIC AMYLOIDOSIS;
D O I：
10.1111/pin.13113
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：556 / 558
页数：3
相关论文
共 50 条
  • [1] AMYLOID POLYNEUROPATHY CAUSED BY WILD-TYPE TRANSTHYRETIN
    Lam, Lynda
    Margeta, Marta
    Layzer, Robert
    MUSCLE & NERVE, 2015, 52 (01) : 146 - 149
  • [2] Assessment of transthyretin instability in patients with wild-type transthyretin amyloid cardiomyopathy
    Iino, Takuya
    Nagao, Manabu
    Tanaka, Hidekazu
    Yoshikawa, Sachiko
    Asakura, Junko
    Nishimori, Makoto
    Shinohara, Masakazu
    Harada, Amane
    Watanabe, Shunsuke
    Ishida, Tatsuro
    Hirata, Ken-ichi
    Toh, Ryuji
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [3] Differential Association of Transthyretin Stability with Variant and Wild-Type Transthyretin Amyloid Cardiomyopathy
    Urina-Jassir, Manuel
    Teruya, Sergio
    Blaner, William S.
    Brun, Pierre-Jacques
    Prokaeva, Tatiana
    Tsai, Felix J.
    Kelly, Jeffery W.
    Maurer, Mathew S.
    Ruberg, Frederick L.
    JACC-HEART FAILURE, 2024, 12 (12) : 2113 - 2115
  • [4] Contribution of wild-type transthyretin to hereditary peripheral nerve amyloid
    Yazaki, M
    Liepnieks, JJ
    Kincaid, JC
    Benson, MD
    MUSCLE & NERVE, 2003, 28 (04) : 438 - 442
  • [5] Therapeutic value of spironolactone in wild-type transthyretin amyloid cardiomyopathy
    Luisa Pinheiro, L.
    Castro, M.
    Tinoco, M.
    Pereira, T.
    Mata, E.
    Azevedo, O.
    Lourenco, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 496 - 496
  • [6] Use of Serum Transthyretin as a Prognostic Indicator and Predictor of Outcome in Cardiac Amyloid Disease Associated With Wild-Type Transthyretin
    Hanson, Jacquelyn L. S.
    Arvanitis, Marios
    Koch, Clarissa M.
    Berk, John L.
    Ruberg, Frederick L.
    Prokaeva, Tatiana
    Connors, Lawreen H.
    CIRCULATION-HEART FAILURE, 2018, 11 (02)
  • [7] Temporal Trends of Wild-Type Transthyretin Amyloid Cardiomyopathy in the Transthyretin Amyloidosis Outcomes Survey
    Nativi-Nicolau, Jose
    Siu, Alfonso
    Dispenzieri, Angela
    Maurer, Mathew S.
    Rapezzi, Claudio
    Kristen, Arnt, V
    Garcia-Pavia, Pablo
    LoRusso, Samantha
    Waddington-Cruz, Marcia
    Lairez, Olivier
    Witteles, Ronald
    Chapman, Doug
    Amass, Leslie
    Grogan, Martha
    JACC: CARDIOONCOLOGY, 2021, 3 (04): : 537 - 546
  • [8] Prognostic factors associated with survival in patients with wild-type transthyretin amyloid cardiomyopathy, treated with tafamidis
    Zemljic, G.
    Frljak, S.
    Poglajen, G.
    Zorz, N.
    Cerar, A.
    Okrajsek, R.
    Bajec, T.
    Vrtovec, B.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 162 - 162
  • [9] Molecular mechanisms and emerging therapies in wild-type transthyretin amyloid cardiomyopathy
    Wu, Danni
    Chen, Wei
    HEART FAILURE REVIEWS, 2024, 29 (02) : 511 - 521
  • [10] Cardiac amyloid in patients with familial amyloid polyneuropathy consists of abundant wild-type transthyretin
    Yazaki, M
    Tokuda, T
    Nakamura, A
    Higashikata, T
    Koyama, J
    Higuchi, K
    Harihara, Y
    Baba, S
    Kametani, F
    Ikeda, S
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 274 (03) : 702 - 706
12345